Register Login
Register to leave comments
  • News bot March 10, 2026, 8:16 p.m.

    🔍 Harr Steve (Executive)

    Company: Sana Biotechnology, Inc. (SANA)

    Report Date: 2026-03-06

    Transaction Summary:

    • Total transactions: 9
    • Derivative instruments: 2
    • Holdings reported: 3
    • Total shares acquired: 91,666
    • Total shares sold: 116,011
    • Total shares held: 1,016,500

    Detailed Transactions and Holdings:

    • Acquired 41,666 shares of Common Stock (Direct)
      Date: 2026-03-06 | Code: M | equity_swap_involved: false | shares_owned_after: 7,918,596.00 | transaction_form_type: 4
    • Acquired 50,000 shares of Common Stock (Direct)
      Date: 2026-03-07 | Code: M | equity_swap_involved: false | shares_owned_after: 7,968,596.00 | transaction_form_type: 4
    • Sold 11,526 shares of Common Stock at $3.13 per share (Direct)
      Date: 2026-03-09 | Code: F | equity_swap_involved: false | shares_owned_after: 7,957,070.00 | transaction_form_type: 4
    • Sold 12,819 shares of Common Stock at $3.1 per share (Direct)
      Date: 2026-03-09 | Code: F | equity_swap_involved: false | shares_owned_after: 7,944,251.00 | transaction_form_type: 4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-06 | Code: H | nature_of_ownership: Held by Harr Family Irrevocable Trust of 2015 dtd 12/28/2015 | shares_owned_after: 682,500.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-06 | Code: H | nature_of_ownership: Held by Brian L Harr TTEE CCH Irrevocable Trust U/A DTD 03/25/2021 | shares_owned_after: 167,000.00 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-06 | Code: H | nature_of_ownership: Held by Brian L Harr TTEE JOH Irrevocable Trust U/A DTD 03/25/2021 | shares_owned_after: 167,000.00 | Footnotes: F1
    • Sold 41,666 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-06 | Code: M | equity_swap_involved: false | shares_owned_after: 125,001.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
    • Sold 50,000 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-07 | Code: M | equity_swap_involved: false | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F2, F4, F4

    Footnotes:

    • F1: Brian L. Harr is the trustee of these trusts, whose sole beneficiaries are members of the reporting person's immediate family.
    • F2: Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
    • F3: The award vested as to 25% of the restricted stock units on March 6, 2026, and the remaining restricted stock units will vest in three equal installments on each of March 6, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
    • F4: The award vested as to 25% of the restricted stock units on each of March 7, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of March 7, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.

Search

News categories